The data indicated that MBNL1-AS1 overexpression elevated the expression of an epithelial marker (E-cadherin) but decreased the expression of mesenchymal marker (N-cadherin and Vimentin), suggesting that MBNL1-AS1 hindered EMT behavior in PAAD cells. This evidence concerns the gene CDH2 and pancreatic adenocarcinoma.